Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Dec;31(6):441-61.
doi: 10.1007/s10928-005-5911-1.

Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLME

Affiliations
Comparative Study

Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLME

Christoffer W Tornøe et al. J Pharmacokinet Pharmacodyn. 2004 Dec.

Abstract

In this paper, the two non-linear mixed-effects programs NONMEM and NLME were compared for their use in population pharmacokinetic/pharmacodynamic (PK/PD) modelling. We have described the first-order conditional estimation (FOCE) method as implemented in NONMEM and the alternating algorithm in NLME proposed by Lindstrom and Bates. The two programs were tested using clinical PK/PD data of a new gonadotropin-releasing hormone (GnRH) antagonist degarelix currently being developed for prostate cancer treatment. The pharmacokinetics of intravenous administered degarelix was analysed using a three compartment model while the pharmacodynamics was analysed using a turnover model with a pool compartment. The results indicated that the two algorithms produce consistent parameter estimates. The bias and precision of the two algorithms were further investigated using a parametric bootstrap procedure which showed that NONMEM produced more accurate results than NLME together with the nlmeODE package for this specific study.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Clin Pharmacol. 2002 Dec;58(9):597-605 - PubMed
    1. J Pharm Sci. 1998 Dec;87(12):1577-84 - PubMed
    1. Oncologist. 2000;5(2):162-8 - PubMed
    1. Pharm Res. 2004 Apr;21(4):574-84 - PubMed
    1. Biometrics. 1994 Jun;50(2):566-75 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources